Freyssin_2023_Neuropharmacol__109733

Reference

Title : Fluoroethylnormemantine (FENM) shows synergistic protection in combination with a sigma-1 receptor agonist in a mouse model of Alzheimer's disease - Freyssin_2023_Neuropharmacol__109733

Author(s) : Freyssin A , Carles A , Guehairia S , Rubinstenn G , Maurice T

Ref : Neuropharmacology , :109733 , 2023

Abstract : Freyssin_2023_Neuropharmacol__109733

ESTHER : Freyssin_2023_Neuropharmacol__109733

PubMedSearch : Freyssin_2023_Neuropharmacol__109733

PubMedID: 37844867

Related information

Citations formats

Freyssin A, Carles A, Guehairia S, Rubinstenn G, Maurice T (2023)
Fluoroethylnormemantine (FENM) shows synergistic protection in combination with a sigma-1 receptor agonist in a mouse model of Alzheimer's disease
Neuropharmacology :109733

Freyssin A, Carles A, Guehairia S, Rubinstenn G, Maurice T (2023)
Neuropharmacology :109733